ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. New Nordic Healthbrands AB's annualizedNet Income for the quarter that ended in Mar. 2026 was €-1.06 Mil.
New Nordic Healthbrands AB's average Total Assets over the quarter that ended in Mar. 2026 was €23.58 Mil. Therefore, New Nordic Healthbrands AB's annualized ROA % for the quarter that ended in Mar. 2026 was -4.51%.
The historical rank and industry rank for New Nordic Healthbrands AB's ROA % or its related term are showing as below:
FRA:N9X'
s ROA % Range Over the Past 10 Years
Min: -3.09 Med: 8.36 Max: 17.6
Current: 1.06
During the past 13 years, New Nordic Healthbrands AB's highest ROA % was 17.60%. The lowest was -3.09%. And the median was 8.36%.
FRA:N9X's ROA % is ranked worse than 66.26% of 1986
companies
in the Consumer Packaged Goods industry
Industry Median: 3.24
vs FRA:N9X: 1.06
New Nordic Healthbrands AB (FRA:N9X) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, New Nordic Healthbrands AB's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Nordic Healthbrands AB ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's ROA % distribution charts can be found below:
* The bar in red indicates where New Nordic Healthbrands AB's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
New Nordic Healthbrands AB (FRA:N9X) has a ROA % of -4.51% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on New Nordic Healthbrands AB and its competitors. According to the industry distribution chart, New Nordic Healthbrands AB ranks #1316 out of 1986 companies in the Consumer Packaged Goods industry, placing it in the top 66.3%.
Is New Nordic Healthbrands AB's ROA % too high?
New Nordic Healthbrands AB's current ROA % is -4.51%. Based on the distribution chart, New Nordic Healthbrands AB ranks #1316 out of 1986 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, New Nordic Healthbrands AB has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's ROA % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, New Nordic Healthbrands AB ranks #1316 out of 1986 companies for ROA %. This places New Nordic Healthbrands AB in the lower half of its industry. The industry median ROA % is 3.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.24, based on 1,986 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on New Nordic Healthbrands AB and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current ROA % is -4.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current ROA % of -4.51%. The stock's GF Value™ is €1.72, compared to a current price of €1.06 — trading 38.4% below its estimated fair value. The current ROA % is -4.51%. New Nordic Healthbrands AB's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current ROA % is -4.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?
Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued.
The current stock price of €1.06 is trading 38.4% below its estimated GF Value™ of €1.72.
Key valuation signals for FRA:N9X:
ROA %: -4.51%
GF Value™: €1.72 vs. price of €1.06 (38.4% below fair value)
No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
59GF Score
Get the complete analysis for FRA:N9X
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N9X has been successfully added to your 
